Olympus Corporation ("Olympus") hereby announces that the closing date of the transfer of all shares of Evident Corporation, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) (the "Transfer") has been scheduled for April 3, [...]

SOUTH PLAINFIELD, NEW JERSEY, USA -- Admera Health, a leading provider of Next-Generation Sequencing services for researchers worldwide, has announced the acquisition of an Illumina NovaSeq X Plus sequencer to bolster its offering. The NovaSeq X Plus is a cutting-edge technology that enables high-throughput sequencing and supports a wide range of applications, including whole genome sequencing, transcriptome sequencing, targeted sequencing, [...]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has become the first service provider using the Olink® Target and Olink® Flex platforms for targeted protein biomarker discovery on the African continent. D-CYPHR is a new facility co-founded by [...]

Tokyo — Evident Corporation ("Evident") announces that the closing date of the transfer of all shares of Evident, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) has been scheduled for April 3, 2023. Reasons for [...]

Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Boston & Ljubljana, Slovenia – Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are [...]

NORTH AUGUSTA, S.C. and DEVENS, Mass. -- AmbioPharm, a worldwide leader in peptide API CDMO services, announces the acquisition of new, disruptive, peptide purification technology developed by YMC which leverages several of YMC’s patented1 twin-column purification processes. Twin-column chromatography or Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) is a continuous chromatographic process which collects a high purity center cut fraction and internally recycles mixed [...]

SINGAPORE -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have announced an extended research partnership that will focus on deep immunophenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated [...]

Leiden – MIMETAS, a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company. The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in our longstanding collaboration with [...]

The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers BOSTON & LAUSANNE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop [...]

- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity & Inclusion and has an executive leadership team that is 50% women. SAN DIEGO -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider [...]